Liquidia Corporation (LQDA)
NASDAQ·Healthcare·Medical - Pharmaceuticals
$45.78
+0.68%
Mkt Cap $3.82B
Analyst Ratings
Buy
17
Hold
5
Sell
0
Price Target (30 analysts)
$98.11
Range $36.00 – $130.00
Implied Upside
+114.3%
Consensus $98.11 vs current $45.78